Cite
Biological and clinical consequences of NPM1 mutations in AML
MLA
Mark D. Minden, et al. “Biological and Clinical Consequences of NPM1 Mutations in AML.” Leukemia, vol. 31, Jan. 2017, pp. 798–807. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....edff2d612c18927b6f5a2efe04ba904e&authtype=sso&custid=ns315887.
APA
Mark D. Minden, Tracy Murphy, E M Heath, Aaron D. Schimmer, Liran I. Shlush, & Steven M. Chan. (2017). Biological and clinical consequences of NPM1 mutations in AML. Leukemia, 31, 798–807.
Chicago
Mark D. Minden, Tracy Murphy, E M Heath, Aaron D. Schimmer, Liran I. Shlush, and Steven M. Chan. 2017. “Biological and Clinical Consequences of NPM1 Mutations in AML.” Leukemia 31 (January): 798–807. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....edff2d612c18927b6f5a2efe04ba904e&authtype=sso&custid=ns315887.